|
Monday, February 28 — 8:00 AM — CC 006 C/D
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section E - Gastrointestinal Pathology
Chaired by: Amitabh Srivastava and Noam Harpaz
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Prognostic Impact of Jass's Proposed Molecular Classification of Colorectal Cancer Based on MSI, CIMP, MGMT, KRAS and BRAF Status.
(730)
I Zlobec, M Bihl, A Foerster, A Rufle, A Lugli - University Hospital Basel, Switzerland
|  Add |
| 8:15 |
Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas.
(716)
E Vakiani, M Janackinaram, J Shia, L Saltz, N Kemeny, M Weiser, D Solit - Memorial Sloan-Kettering Cancer Center, New York City, NY
| Add |
| 8:30 |
Two-Antibody Screen with PMS2 and MSH6 Is Equally as Effective as Four Antibodies for Identification of Mismatch Repair Defects in 1000 Colorectal Cancers.
(689)
M Redston, R Lash - Caris Life Sciences, Newton, MA and Irving, TX
| Add |
| 8:45 |
Can a Three-Marker Panel (NR-21, BAT-25 and MONO-27) Accurately Detect Microsatellite High (MSI-H) Colorectal Tumors without Control DNA?
(682)
DT Patil, MP Bronner, TP Plesec, CR Fraser, X Liu - Cleveland Clinic
| Add |
| 9:00 |
Determination of KRAS Status in Highly Challenging Rectal Adenocarcinomas after Neoadjuvant Treatment.
(605)
F Boissiere-Michot, H Frugier, E Lopez-Crapez, M-L Berthe, F Bibeau - CRLC Val d'Aurelle, Montpellier, France; CHU . A. de Villeneuve, Montpellier, France
| Add |
| 9:15 |
Tumor Deposits in Rectal Adenocarcinoma after Neoadjuvant Chemoradiation Are Associated with Advanced Stage and Tumor Recurrence.
(626)
P Gopal, MK Washington - Vanderbilt University Medical Center, Nashville, TN
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Peritoneal Elastic Laminal Invasion of Colorectal Cancer: The Diagnostic Utility and Clinicopathological Relationship.
(655)
M Kojima, K Nakajima, G Ishii, N Saito, A Ochiai - National Cancer Center Hospital East, Kashiwa, Chiba, Japan
| Add |
| 11:15 |
LINE-1 Extreme Hypomethylator Is a New Distinct Molecular Subtype Associated with Young Age and Poor Prognosis: Bioinformatic Analysis of 1190 Colorectal Cancers.
(676)
S Ogino, C Fuchs, C Huttenhower - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Harvard School of Public Health, Boston, MA
| Add |
| 11:30 |
The Significance of IGG4 in Inflammatory Bowel Disease.
(719)
RK Virk, GY Lauwers, V Deshpande - UMass Memorial Medical Center, Worcester, MA; Massachusetts General Hospital, Boston
| Add |
| 11:45 |
Incomplete Goblet Cell Maturation: A Distinctive Form of Flat Dysplasia in IBD.
(686)
L Qin, H Zhu, M Raoufi, N Harpaz - Mount Sinai School of Medicine, New York, NY
| Add |
|
|
